Article
Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial
24 Aug 2017
Abstract excerpt
Over the past decade, vectors derived from adeno-associated virus (AAV) have established themselves as a powerful tool for in vivo gene transfer, allowing long-lasting and safe transgene expression in a variety of human tissues. Nevertheless, clinical trials demonstrated how B and T cell immune responses directed against the AAV capsid, likely arising after natural infection with wild-type AAV, might potentially...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
